Levels of circulating microparticles in patients with chronic cardiorenal disease

Journal of Atherosclerosis and Thrombosis

Volumn 22, Issue 3, 2015, Pages 247-256

  Chen, Yung Lung ^a   Chen, Chih Hung ^a   Wallace, Christopher Glenn ^b   Wang, Hui Ting ^a   Yang, Chih Chao ^a   Yip, Hon Kan ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b ROYAL DEVON AND EXETER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Cardiorenal syndrome; Chronic kidney disease; Coronary artery disease; Microparticles

Indexed keywords

CREATININE; MICROSPHERE;

AGED; ANGINA PECTORIS; APOPTOSIS; ARTICLE; BLOOD SAMPLING; CARDIORENAL SYNDROME; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMBRANE MICROPARTICLE; QUANTITATIVE ANALYSIS; RISK FACTOR; BLOOD; CHRONIC DISEASE; HEART DISEASE; KIDNEY DISEASE; MIDDLE AGED;

AGED; CHRONIC DISEASE; FEMALE; HEART DISEASES; HUMANS; KIDNEY DISEASES; MALE; MICROSPHERES; MIDDLE AGED;

EID: 84925371818     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.26658     Document Type: Article

References (45)

1. Shlipak MG, Massie BM: The clinical challenge of cardiorenal syndrome. Circulation, 2004; 110: 1514-1517
2. Ronco C, McCullough P, Anker SD, Anand I, Aspromonte N, Bagshaw SM, Bellomo R, Berl T, Bobek I, Cruz DN, Daliento L, Davenport A, Haapio M, Hillege H, House AA, Katz N, Maisel A, Mankad S, Zanco P, Mebazaa A, Palazzuoli A, Ronco F, Shaw A, Sheinfeld G, Soni S, Vescovo G, Zamperetti N, Ponikowski P, Acute Dialysis Quality Initiative (ADQI) consensus group: Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative. Eur Heart J, 2010; 31: 703-711
3. Ronco C, Haapio M, House AA, Anavekar N, Bellomo R: Cardiorenal syndrome. J Am Coll Cardiol, 2008; 52: 1527-1539
4. Sadeghi HM, Stone GW, Grines CL, Mehran R, Dixon SR, Lansky AJ, Fahy M, Cox DA, Garcia E, Tcheng JE, Griffin JJ, Stuckey TD, Turco M, Carroll JD: Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation, 2003; 108: 2769-2775
5. Yamaguchi J, Kasanuki H, Ishii Y, Yagi M, Nagashima M, Fujii S, Koyanagi R, Ogawa H, Hagiwara N, Haze K, Sumiyoshi T, Honda T, HIJC Investigators: Serum creatinine on admission predicts long-term mortality in acute myocardial infarction patients undergoing successful primary angioplasty: data from the Heart Institute of Japan Acute Myocardial Infarction (HIJAMI) Registry. Circ J, 2007; 71: 1354-1359
6. Seyfarth M, Kastrati A, Mann JF, Ndrepepa G, Byrne RA, Schulz S, Mehilli J, Schömig A: Prognostic value of kidney function in patients with ST-elevation and Non-STelevation acute myocardial infarction treated with percutaneous coronary intervention. Am J Kidney Dis, 2009; 54: 830-839
7. Cardarelli F, Bellasi A, Ou FS, Shaw LJ, Veledar E, Roe MT, Morris DC, Peterson ED, Klein LW, Raggi P: Combined impact of age and estimated glomerular filtration rate on in-hospital mortality after percutaneous coronary intervention for acute myocardial infarction (from the American College of Cardiology National Cardiovascular Data Registry). Am J Cardiol, 2009; 103: 766-771
8. Koganei H, Kasanuki H, Ogawa H, Tsurumi Y: Association of glomerular filtration rate with unsuccessful primary percutaneous coronary intervention and subsequent mortality in patients with acute myocardial infarction: from the HIJAMI registry. Circ J, 2008; 72: 179-185
9. Muntner P, He J, Hamm L, Loria C, Whelton PK: Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol, 2002; 13: 745-753
10. Nakamura K, Okamura T, Hayakawa T, Kadowaki T, Kita Y, Ohnishi H, Saitoh S, Sakata K, Okayama A, Ueshima H, NIPPON DATA90 Research Group: Chronic kidney disease is a risk factor for cardiovascular death in a community- based population in Japan: NIPPON DATA90. Circ J, 2006; 70: 954-959
11. Wolfe RA, Port FK, Webb RL, Bloembergen WE, Hirth R, Young EW, Ojo AO, Strawderman RL, Parekh R, Stack A, Tedeschi PJ, Hulbert-Shearon T, Ashby VB, Callard S, Hanson J, Jain A, Meyers-Purkiss A, Roys E, Brown P, Wheeler JR, Jones CA, Greer JW, Agodoa LY: Introduction to the excerpts from the United States Renal Data System 1999 Annual Data Report. Am J Kidney Dis, 1999; 34: S1-S3
12. Herzog CA: Diagnosis and treatment of ischemic heart disease in dialysis patients. Curr Opin Nephrol Hypertens, 1997; 6: 558-565
13. Herzog CA, Ma JZ, Collins AJ: Poor long-term survival after acute myocardial infarction among patients on longterm dialysis. N Engl J Med, 1998; 339: 799-805
14. Chertow GM, Normand SL, Silva LR, McNeil BJ: Survival after acute myocardial infarction in patients with end-stage renal disease: Results from the cooperative cardiovascular project. Am J Kidney Dis, 2000; 35: 1044- 1051
15. Foley RN, Parfrey PS, Sarnak MJ: Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis, 1998; 32: S112-S119
16. Dickhout JG, Carlisle RE, Austin RC: Interrelationship between cardiac hypertrophy, heart failure, and chronic kidney disease: endoplasmic reticulum stress as a mediator of pathogenesis. Circ Res, 2011; 108: 629-642
17. Sayed AS, Xia K, Salma U, Yang T, Peng J: Diagnosis, Prognosis and Therapeutic Role of Circulating miRNAs in Cardiovascular Diseases. Heart Lung Circ, 2014; pii: S1443-9506(14)00030-4
18. Wang F, Long G, Zhao C, Li H, Chaugai S, Wang Y, Chen C, Wang DW: Plasma microRNA-133a is a new marker for both acute myocardial infarction and underlying coronary artery stenosis. J Transl Med, 2013; 11: 222
19. Wang X, Ward PA: Opportunities and challenges of disease biomarkers: a new section in the Journal of Translational Medicine. J Transl Med, 2012; 10: 220
20. Witasp A, Rydén M, Carrero JJ, Qureshi AR, Nordfors L, Näslund E, Hammarqvist F, Arefin S, Kublickiene K, Stenvinkel P: Elevated circulating levels and tissue expres sion of pentraxin 3 in uremia: a reflection of endothelial dysfunction. PLoS One, 2013; 8: e63493
21. Kim HR, Nam BY, Kim DW, Kang MW, Han JH, Lee MJ, Shin DH, Doh FM, Koo HM, Ko KI, Kim CH, Oh HJ, Yoo TH, Kang SW, Han DS, Han SH: Circulating α -klotho levels in CKD and relationship to progression. Am J Kidney Di, 2013; 61: 899-909
22. Shen SJ, Hu ZX, Li QH, Wang SM, Song CJ, Wu DD, He JL, Guan JC, Shan JP: Implications of the changes in serum neutrophil gelatinase-associated lipocalin and cystatin C in patients with chronic kidney disease. Nephrology (Carlton), 2014; 19: 129-135
23. Chen J, Zhang X, Zhang H, Lin J, Zhang C, Wu Q, Ding X: Elevated Klotho promoter methylation is associated with severity of chronic kidney disease. PLoS One, 2013; 8: e79856
24. Jungbauer CG, Birner C, Jung B, Buchner S, Lubnow M, von Bary C, Endemann D, Banas B, Mack M, Böger CA, Riegger G, Luchner A: Kidney injury molecule-1 and N-acetyl-β-D-glucosaminidase in chronic heart failure: possible biomarkers of cardiorenal syndrome. Eur J Heart Fail, 2011; 13: 1104-1110
25. Mostefai HA, Andriantsitohaina R, Martinez MC: Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. Physiol Res, 2008; 57: 311-320
26. Mallat Z, Benamer H, Hugel B, Benessiano J, Steg PG, Freyssinet JM, Tedgui A: Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation, 2000; 101: 841-843
27. Martin S, Tesse A, Hugel B, Martinez MC, Morel O, Freyssinet JM, Andriantsitohaina R: Shed membrane particles from T lymphocytes impair endothelial function and regulate endothelial protein expression. Circulation, 2004; 109: 1653-1659
28. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R: Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol, 2005; 288: H1004-H1009
29. Mezentsev A, Merks RM, O'Riordan E, Chen J, Mendelev N, Goligorsky MS, Brodsky SV: Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress. Am J Physiol Heart Circ Physiol, 2005; 289: H1106-H1114
30. Martinez MC, Larbret F, Zobairi F, Coulombe J, Debili N, Vainchenker W, Ruat M, Freyssinet JM: Transfer of differentiation signal by membrane microvesicles harboring hedgehog morphogens. Blood, 2006; 108: 3012-3020
31. Nomura S, Uehata S, Saito S, Osumi K, Ozeki Y, Kimura Y: Enzyme immunoassay detection of platelet-derived microparticles and RANTES in acute coronary syndrome. Thromb Haemost, 2003, 89: 506-512
32. Joop K, Berckmans RJ, Nieuwland R, Berkhout J, Romijn FP, Hack CE, Sturk A: Microparticles from patients with multiple organ dysfunction syndrome and sepsis support coagulation through multiple mechanisms. Thromb Haemost, 2001; 85: 810-820
33. Ogata N, Imaizumi M, Nomura S, Shozu A, Arichi M, Matsuoka M, Matsumura M: Increased levels of plateletderived microparticles in patients with diabetic retinopa thy. Diabetes Res Clin Pract, 2005; 68: 193-201
34. Daniel L, Fakhouri F, Joly D, Mouthon L, Nusbaum P, Grunfeld JP, Schifferli J, Guillevin L, Lesavre P, Halbwachs- Mecarelli L: Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int, 2006; 69: 1416-1423
35. Tesselaar ME, Romijn FP, Van Der Linden IK, Prins FA, Bertina RM, Osanto S: Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost, 2007; 5: 520-527
36. Nomura S, Kagawa H, Ozaki Y, Nagahama M, Yoshimura C, Fukuhara S: Relationship between platelet activation and cytokines in systemic inflammatory response syndrome patients with hematological malignancies. Thromb Res, 1999; 95: 205-213
37. Janowska-Wieczorek A, Marquez-Curtis LA, Wysoczynski M, Ratajczak MZ: Enhancing effect of platelet-derived microvesicles on the invasive potential of breast cancer cells. Transfusion, 2006; 46: 1199-1209
38. Kanazawa S, Nomura S, Kuwana M, Muramatsu M, Yamaguchi K, Fukuhara S: Monocyte-derived microparticles may be a sign of vascular complication in patients with lung cancer. Lung Cancer, 2003; 39: 145-149
39. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lente F, Chronic Kidney Disease Epidemiology Collaboration: Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular fil tration rate. Ann Intern Med, 2006; 145: 247-254
40. Tseng CC, Wang CC, Chang HC, Tsai TH, Chang LT, Huang KT, Leu S, Yen CH, Liu SF, Chen CH, Yang CT, Yip HK, Lin MC: Levels of circulating microparticles in lung cancer patients and possible prognostic value. Dis Markers, 2013; 35: 301-310
41. Freyssinet JM, Dignat-George F: More on: measuring circulating cell-derived microparticles. J Thromb Haemost, 2005; 3: 613-614
42. Boulanger CM, Amabile N, Guérin AP, Pannier B, Leroyer AS, Mallat CN, Tedgui A, London GM: In vivo shear stress determines circulating levels of endothelial microparticles in end-stage renal disease. Hypertension, 2007; 49: 902-908
43. Daniel L, Fakhouri F, Joly D, Mouthon L, Nusbaum P, Grunfeld JP, Schifferli J, Guillevin L, Lesavre P, Halbwachs- Mecarelli L: Increase of circulating neutrophil and platelet microparticles during acute vasculitis and hemodialysis. Kidney Int, 2006; 69: 1416-1423
44. Daniel L, Dou L, Berland Y, Lesavre P, Mecarelli-Halbwachs L, Dignat-George F: Circulating microparticles in renal diseases Nephrol. Dial. Transplant, 2008; 23: 2129- 2132
45. Faure V, Dou L, Sabatier F, Cerini C, Sampol J, Berland Y, Brunet P, Dignat-George F: Elevation of circulating endothelial microparticles in patients with chronic renal failure. J Thromb Haemost, 2006; 4: 566-573